Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Donor and recipient factors affecting the twelve month graft function

M Krajewska, K Kościelska-Kasprzak, D Drulis-Fajdasz, W Weyde, K Madziarska, O Mazanowska, M Kusztal, M Klinger

Ann Transplant 2009; 14(1): 57-57 :: ID: 880406

Abstract

The aim of the study was to evaluate an impact of clinical characteristics potentially important for graft function during the first year.
Material/Methods: The study group encompassed 125 kidney recipients (46 F, 79 M, 46.8±12.3 y.) The observation lasted a minimum of twelve months (30.9±13.0).
Results: The graft function depended on donor and recipient's ages. An influence of gender matching and smoking before transplantation was observed. A negative influence of PRA was noted. An adverse impact of the duration of dialysis on eGFR was found. A signifi cant dependence of DGF and AR was shown. The importance of UA and cholesterol concentration was revealed. Higher CRP concentration was related to higher values of eGFR. In diabetic patients, mean eGFR was lower than in recipients without diabetes. A significant impact of hypertension detected at third month, its intensity, and the number of applied medications were negatively correlated with the eGFR. The presence of proteinuria a month after the procedure was linked to a lower values of GFR. This study indicated a connection between graft function's deterioration and the occurrence of leukopenia and infectious complications.
Conclusions: 1. The novel finding of the study is the positive correlation between CRP level within first three months and eGFR suggesting that higher, but in the normal range CRP is the indicator of more effective IR healing.
2. In addition the multiple factors were revealed associated with recipient
co-morbidities, intensity of the rejection process, and transplanted organ
quality which could be modified by appropriate treatment.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358